The Latest Cardiac and Vascular News
MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today reported financial results for the year ended December 31, 2021 and provided a business update. “With the advancement of our […]
SUNNYVALE, Calif., March 29, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ended December 31, 2021 and filed its annual report on Form 10-K for the year ended December 31, […]
Provides enhanced credit facility up to $100 million with favorable terms and facility maturity extended to March 2027 SAN FRANCISCO, March 29, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, announced it has amended its existing […]
Fourth quarter 2021 revenue of $23.0 million contributed to record full year revenue of $81.6 million, 46% growth over the prior year Established over 75 new customer accounts, expanding and diversifying revenue base Substantial cash and investments of $657.7 million at year-end Maintaining 2022 full year revenue guidance of $105-110 […]
TOLEDO, Ohio & DIEST, Belgium–(BUSINESS WIRE)–NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its nearing acquisition of Medanex Clinic, a Belgium-based European preclinical research organization. Founded in 2010, Medanex focuses on providing exceptional preclinical services to the medical device industry in Europe and across the globe. […]
The leasing and finance program provides a non-recourse financial solution for PURE EP™ to improve purchase flexibility for U.S. hospitals Westport, CT, March 29, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve […]
LOS ANGELES, March 29, 2022 /PRNewswire/ — Australian medical technology company, Artrya Limited, creator of the AI-based solution, Artrya Salix, that supports physicians in the diagnosis of coronary artery disease, today announces the formation of the Company’s American subsidiary, Artrya USA, Inc. (Artrya US) with its headquarters in Los Angeles, California. Ted Schwab and Jory Tremblay have been […]
DALLAS, March 29, 2022 /PRNewswire/ — Dynamic Infusion Therapy, LLC (“DIT”), a market leading provider of outsourced vascular access services, has announced the acquisition of Vascular Access Consultants based in Austin, Texas. Vascular Access Consultants has been providing expert services to healthcare facilities in Austin and the surrounding areas for the past 26 years under […]
– Proceeds to fund ACCESS 2 – a randomized clinical trial evaluating Sirogen™ for improving hemodialysis AV Fistula outcomes in high-risk patients – CRESSKILL, N.J., March 29, 2022 /PRNewswire/ — Vascular Therapies, Inc. a clinical-stage biopharma company focused on improving vascular access outcomes in patients with kidney disease, today announced the closing […]
— Advancing late-stage clinical and preclinical programs of the Human Acellular Vessel™ (HAV™) and other engineered tissues across several indications – — Multiple publications and scientific meeting presentations highlighting clinical and preclinical HAV results – — Conference call and live webcast at 8:00 am ET today – DURHAM, N.C., March […]
